Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/23/10 → 9/23/13 |
Funding
- Boehringer Ingelheim Pharmaceuticals, Inc. (205.452)
Prot# 205.452: A randomised, active-controlled, double-blind, double-dummy, parallel group design, multi-center trial to compare the efficacy and safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution delivered by the Respimat® Inhaler with Tiotropium i
- Kalhan, Ravi (PD/PI)
- Rosenberg, Sharon Reifler (Co-PD/PI)
- Smith, Lewis J (Co-PD/PI)
Project: Research project